STERILE OPHTHALMIC CDMO
News & Events
Pillar5 Pharma will be attending CPHI, Worldwide in Frankfurt Germany the week of November 4th, 2019
As a Contract Development Manufacturing Organization, we are hoping to meet with companies that are interested in both Solid Dose capabilities as well as Sterile Ophthalmic capabilities.
Having over 50 years experience specializing in Ophthalmic products, Pillar5 Pharma is now excited to be in the business looking for multi-dose preservative free capacity.
Having a great record with FDA and Health Canada audits make us confident that we would be a great fit for your new partner!
Please contact us @ P5info@pillar5pharma.com to set up a meet and greet.
As Pillar5 Pharma currently completes a major $11M expansion to their sterile ophthalmic suite, they are looking to partner with select companies for this capacity increase, which will include multi-dose preservative free (MDPF) capabilities.
Preservative free has experienced great growth in Europe and is currently in competition with Blow-Fill Seal. Preservative Free is more convenient and affordable compared to unit-dose as it has calibrated drops, one drop at a time. These devices have a one-way valve that ensure that no contaminated liquid can be re-introduced into the container after a drop has been dispensed.
This device is a preservative-free mutlidose system that avoids the need for preservatives in the product. As you are aware, the standard eye drop is sterile when it is packaged, but upon the first use, it is no longer sterile. Preservatives have been shown to be harmful to the eye and can cause irritation, discomfort, or dry eye which leads the patient to discontinue use of the product.